Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07124208Not ApplicableRecruiting

A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes

Role: lead

NCT06147999Not ApplicableRecruiting

Impact of a Biophoton Therapy on Patients With Brain Disorders

Role: lead

NCT06049849Not ApplicableCompleted

Can Patients With Chronic Stroke Regain Living Independence by Daily Energizing With Biophoton Generators

Role: lead

NCT06915012Not ApplicableRecruiting

Impact of Biophoton Therapy on Chronic Severe Arthritis Pain

Role: lead

NCT06855459Not ApplicableRecruiting

The Impact of Biophoton Therapy on Self-Grown Stem Cells

Role: lead

NCT05898334Not ApplicableCompleted

Impact of Biophoton Generator on Chronic-Stroke Patients' Recovery

Role: lead

All 6 trials loaded